ArticleVaccines2022

In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19.

Mahmoud Elkazzaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.